CENTRALLY-ACTING ANTI-OBESITY DRUGS Monoamine Neurotransmitter Modulators With the exception of the glucagon-like peptide 1 (GLP-1) receptor agonist liraglutide, currently available weight loss medications act on the central nervous system to enhance dopamine, norepinephrine, and serotonin action to enhance satiety, diminish hunger, and consequently affect weight loss
Dedicated to providing individualized solutions, we recognize Wegovy as an outstanding choice
Practical tactics: aim for a palm-sized portion of protein at each meal, and use moist cooking methods like poaching, baking with a sauce, or slow-cooking to make chewing and digestion easier when appetite is low
While these are often benign, they always warrant a clinical physical examination
Weekly Formulations Contemporary guidance for GLP-1 cessation before surgery is evolving